242 related articles for article (PubMed ID: 8310516)
1. Hyperacute xenograft rejection in the swine-to-human donor-recipient combination. In vitro analysis of complement activation.
Zhao Z; Termignon JL; Cardoso J; Chéreau C; Gautreau C; Calmus Y; Houssin D; Weill B
Transplantation; 1994 Jan; 57(2):245-9. PubMed ID: 8310516
[TBL] [Abstract][Full Text] [Related]
2. Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor.
Dalmasso AP; Platt JL
Transplantation; 1993 Nov; 56(5):1171-6. PubMed ID: 8249120
[TBL] [Abstract][Full Text] [Related]
3. Human complement activation via the alternative pathway on porcine endothelium initiated by IgA antibodies.
Schaapherder AF; Gooszen HG; te Bulte MT; Daha MR
Transplantation; 1995 Aug; 60(3):287-91. PubMed ID: 7645041
[TBL] [Abstract][Full Text] [Related]
4. A synthetic dextran derivative inhibits complement activation and complement-mediated cytotoxicity in an in vitro model of hyperacute xenograft rejection.
Thomas H; Maillet F; Letourneur D; Jozefonvicz J; Kazatchkine MD; Fischer E
Transplant Proc; 1996 Apr; 28(2):593-4. PubMed ID: 8623290
[No Abstract] [Full Text] [Related]
5. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients.
Dalmasso AP; Vercellotti GM; Fischel RJ; Bolman RM; Bach FH; Platt JL
Am J Pathol; 1992 May; 140(5):1157-66. PubMed ID: 1580328
[TBL] [Abstract][Full Text] [Related]
6. Xenogeneic serum promotes leukocyte-endothelium interaction under flow through two temporally distinct pathways: role of complement and nuclear factor-kappaB.
Morigi M; Zoja C; Colleoni S; Angioletti S; Imberti B; Donadelli R; Remuzzi A; Remuzzi G
J Am Soc Nephrol; 1999 Oct; 10(10):2197-207. PubMed ID: 10505697
[TBL] [Abstract][Full Text] [Related]
7. Reaction of complement with endothelial cells in a model of xenotransplantation.
Dalmasso AP; Platt JL; Bach FH
Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):31-5. PubMed ID: 1718641
[TBL] [Abstract][Full Text] [Related]
8. [Xenotransplantation: physiopathology of hyperacute and differentiated rejection, and therapeutic perspectives].
Malassagne B; Calmus Y; Houssin D; Weill B
Pathol Biol (Paris); 2000 May; 48(4):377-82. PubMed ID: 10868402
[TBL] [Abstract][Full Text] [Related]
9. Sulfonated dextran inhibits complement activation and complement-dependent cytotoxicity in an in vitro model of hyperacute xenograft rejection.
Thomas H; Maillet F; Letourneur D; Jozefonvicz J; Fischer E; Kazatchkine MD
Mol Immunol; 1996; 33(7-8):643-8. PubMed ID: 8760276
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of tissue injury in hyperacute xenograft rejection.
Platt JL
ASAIO J; 1992; 38(1):8-16. PubMed ID: 1554921
[TBL] [Abstract][Full Text] [Related]
11. Comparison between aortic and sinusoidal liver endothelial cells as targets of hyperacute xenogeneic rejection in the pig to human combination.
Cattan P; Zhang B; Braet F; Atia N; Conti F; Conjeaud H; Weill B; Chereau C; Houssin D; Calmus Y
Transplantation; 1996 Sep; 62(6):803-10. PubMed ID: 8824481
[TBL] [Abstract][Full Text] [Related]
12. Mouse-to-rabbit xenotransplantation: a new small animal model of hyperacute rejection mediated by the classical complement pathway.
Kerr SR; Dalmasso AP; Apasova EV; Chen SS; Kirschfink M; Matas AJ
Transplantation; 1999 Feb; 67(3):360-5. PubMed ID: 10030279
[TBL] [Abstract][Full Text] [Related]
13. Prevention of hyperacute xenograft rejection by intravenous immunoglobulin in the pig-to-human combination.
Gautreau C; Cardoso J; Woimant G; Zhao Z; Chereau C; Cherruau B; Vandeginste N; Devillier P; Houssin D
Transplant Proc; 1994 Jun; 26(3):1281. PubMed ID: 8029908
[No Abstract] [Full Text] [Related]
14. The role of natural antibodies in the activation of xenogenic endothelial cells.
Platt JL; Lindman BJ; Geller RL; Noreen HJ; Swanson JL; Dalmasso AP; Bach FH
Transplantation; 1991 Dec; 52(6):1037-43. PubMed ID: 1750066
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyperacute rejection.
Dalmasso AP; Vercellotti GM; Platt JL; Bach FH
Transplantation; 1991 Sep; 52(3):530-3. PubMed ID: 1716798
[TBL] [Abstract][Full Text] [Related]
16. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.
Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N
Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716
[TBL] [Abstract][Full Text] [Related]
17. Hypodermin A, a new inhibitor of human complement for the prevention of xenogeneic hyperacute rejection.
Malassagne B; Regimbeau JM; Taboit F; Troalen F; Chéreau C; Moiré N; Attal J; Batteux F; Conti F; Calmus Y; Houssin D; Boulard C; Houdebine LM; Weill B
Xenotransplantation; 2003 May; 10(3):267-77. PubMed ID: 12694547
[TBL] [Abstract][Full Text] [Related]
18. Protection of hDAF-transgenic porcine endothelial cells against activation by human complement: role of the membrane attack complex.
Fecke W; Long J; Richards A; Harrison R
Xenotransplantation; 2002 Mar; 9(2):97-105. PubMed ID: 11897002
[TBL] [Abstract][Full Text] [Related]
19. A new in vitro model for the study of pig-to-human vascular hyperacute rejection.
Bennet W; Sundberg B; Elgue G; Larsson R; Korsgren O; Nilsson B
Xenotransplantation; 2001 Aug; 8(3):176-84. PubMed ID: 11472625
[TBL] [Abstract][Full Text] [Related]
20. Complement mediates attenuation of endothelium-dependent relaxations in canine coronary arteries after porcine serum exposure: a mechanism for vascular thrombosis in xenograft hyperacute rejection.
Cable DG; Hisamochi K; Schaff HV
Circulation; 1997 Nov; 96(9 Suppl):II-58-63; discussion II-63-4. PubMed ID: 9386076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
